Regular ArticleBehavioral and Neurochemical Effects of Wild-Type and Mutated Human α-Synuclein in Transgenic Mice
References (52)
- et al.
Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
Neuron
(2000) - et al.
Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by alpha-synuclein immunocytochemistry
Neurosci. Lett.
(1999) - et al.
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss
Brain Res.
(1999) - et al.
A new device for the rapid measurement of impaired motor function in mice
Pharm. Biochem. Behav.
(1977) - et al.
Cocaine reward and MPTP toxicity:alteration by regional variant dopamine transporter overexpression
Brain Res. Mol. Brain Res.
(1999) - et al.
A strain-specific modifier on mouse chromosome 4 controls the methylation of independent transgene loci
Cell
(1991) - et al.
Differential strain suscedptibility following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration acts in an autosmal dominant fashion: Quantitative analysis in seven strains of Mus musculus
Brain Res.
(1999) Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasi of ectopic cells
Dev. Biol.
(1995)- et al.
Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
Neurobiol. Dis.
(2001) - et al.
Effects of estrogen treatment on sensorimotor task performance and brain dopamine concentrations in gonadectomized male and female CD-1 mice
Horm. Behav.
(1994)
AMPA receptors are involved in the expression of amphetmine-induced behavioral sensitization, but not in the expression of amphetamine-induced conditioned activity in mice
Neuropharmacology
(1998)
Dopamine transmporters and neuronal injury
TIPS
(1999)
5′upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice
Mol. Brain Res.
(1994)
High resolution two-dimensional electrophoresis of proteins
J. Biol. Chem.
(1975)
Constitutive phosphorylation of the Parkinosn's disease associated α-synuclein
J. Biol. Chem.
(2000)
Early ontogeny of catecholaminergic cell linearge in brain and peripheral neurons monitored by tyrosine hydroxylase-lacZ transgene
Mol. Brain Res.
(1996)
Knockout of the vesicular monoamine transporter-2 gene results in neonatal death and supersensitivity to cocaine and amphetamine
Neuron
(1997)
MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum
J. Pharmacol. Exp. Ther.
(1993)
Genetic polymorphisms in Parkinson's disease
Neurotoxicology
(1998)
Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas
J. Neurosci. Res.
(1989)
Synucleins in synaptic plasticity and neurodegenerative disorders
J. Neurosci. Res.
(1999)
Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions
Nature Genet.
(2000)
A Drosophila model of Parkinson's disease
Nature
(2000)
α-Synuclein and Parkinson's disease: Selective neurodegenerative effects of α-synuclein fragment on dopaminergic neurons in vivo and in vitro
Ann. Neurol.
(2000)
Dopamine transporter is required for in vivo MPTP neurotoxicity: Evidence from mice lacking the transporter
J. Neurochem.
(1997)
Cited by (0)
Copyright © 2002 Elsevier Science (USA). All rights reserved.